ALPHA TRIBE

Hester Biosciences LimitedUpdates, 12-11-2025: General Updates

12-11-2025 | 03:36 pm

HesterBio's H1 FY26 saw India sales drop (Q2: 64 Cr, down 12%) due to delayed government animal health programs. Consolidated net profit jumped 99% (FX effect). Poultry segment grew 18%, and the H9N2 vaccine was approved. 182 Cr plant capex will boost future growth.

No comments yet. Be the first to comment!

All announcements from Hester Biosciences Limited